SCHEMBL19982293

SCHEMBL19982293

C/C=C\C=C/c1ccc(/C=C/c2[nH]cnc2[N+](=O)[O-])cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.41
APP P05067 1/20 0.41
MAPT P10636 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
POLB P06746 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
PTGS2 P35354 5/20 0.34
GALK1 P51570 1/20 0.34
PTGS1 P23219 2/20 0.31
NFE2L2 Q16236 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CYP19A1 P11511 2/20 0.31
CYP3A4 P08684 1/20 0.31
NAMPT P43490 1/20 0.31
XDH P47989 1/20 0.31
FBP1 P09467 2/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19982190 0.82 EGFR (0.46) TAAR1APPMAPTNPC1RAB9A
SCHEMBL19982272 0.82 TAAR1 (0.43) TAAR1APPMAPTNPC1RAB9A
SCHEMBL10102686 0.81 TAAR1 (0.60) TAAR1MAPTNPC1RAB9AMEN1
SCHEMBL22929156 0.81 MEN1 (0.53) TAAR1MAPTNPC1RAB9AMEN1
SCHEMBL19982086 0.80 TAAR1 (0.51) TAAR1MAPTNPC1RAB9AMEN1
SCHEMBL19982297 0.78 FBP1 (0.50) TAAR1MAPTNPC1RAB9AMEN1
SCHEMBL22929138 0.78 TAAR1 (0.39) TAAR1MAPTNPC1RAB9AMEN1
SCHEMBL19982298 0.77 PTGS2 (0.48) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL22929137 0.75 MAOA (0.44) TAAR1MAPTNPC1RAB9AMEN1
SCHEMBL19982296 0.74 TLR4 (0.46) TAAR1MAPTNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018053446-A1 YAP1 INHIBITORS THAT TARGET THE INTERACTION OF YAP1 WITH OCT4 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2018-03-22 WO disclosed